Results 131 to 140 of about 4,587 (195)

iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis. [PDF]

open access: yesStem Cell Res Ther
Suzuki T   +14 more
europepmc   +1 more source

Tuberous Sclerosis Complex-Associated Tubulointerstitial Kidney Disease. [PDF]

open access: yesKidney Int Rep
Sakhi H   +7 more
europepmc   +1 more source

Exome Sequencing in Saudi Arabian Pediatric Kidney Disease Single-Center Cohort. [PDF]

open access: yesKidney Int Rep
Lemberg K   +23 more
europepmc   +1 more source

Life-Threatening Noninfectious Complications of Peritoneal Dialysis in an Infant with End-Stage Kidney Disease. [PDF]

open access: yesPediatr Rep
Teng CT   +8 more
europepmc   +1 more source

WCN25-1253 SMALL MOLECULE DRUG TREATMENTS FOR INHERITED KIDNEY DISEASE: NEPHRONOPHTHISIS

open access: yesKidney International Reports
Praveen Dhondurao Sudhindar   +4 more
doaj   +1 more source

Biallelic <italic>TMEM72</italic> Variants in Patients with a Nephronophthisis-Like Phenotype.

open access: yesNephron
Claus LR   +34 more
europepmc   +1 more source

Clinical, genetic and bioinformatic analysis of Saudi families with Joubert syndrome and related disorders. [PDF]

open access: yesHum Genomics
Alafghani R   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy